Zymeworks, Inc. (ZYME)
24.42
+0.49
(+2.05%)
USD |
NASDAQ |
May 18, 16:00
25.00
+0.58
(+2.38%)
After-Hours: 19:09
Zymeworks Total Assets (Quarterly) : 478.22M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.397B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| Vertex Pharmaceuticals, Inc. | 26.48B |
| AbbVie, Inc. | 136.46B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 314.63M |
| Shareholders Equity (Quarterly) | 163.59M |
| Debt to Equity Ratio | 1.611 |
| Current Ratio | 10.82 |
| Net Debt Paydown Yield | -2.66% |